TCG
AMGN icon

Transcendent Capital Group’s Amgen AMGN Stock Holding History

Transcendent Capital Group’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-123
Closed -$32.1K – 101
2024
Q4 		$32.1K Hold
123
– – 0.02% 236
2024
Q3 		$39.6K Sell
123
-145
-54% -$47.4K 0.02% 224
2024
Q2 		$83.9K Sell
268
-8
-3% -$2.35K 0.05% 146
2024
Q1 		$78.5K Sell
276
-6
-2% -$1.76K 0.05% 156
2023
Q4 		$81.1K Buy
+282
New +$76.8K 0.05% 115

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Transcendent Capital Group's AMGN Position: Q1 2025 in Review

Transcendent Capital Group sold out of Amgen (AMGN) in Q1 2025, closing a stake of 123 shares — an estimated $32.1K sold.

Transcendent Capital Group first reported a position in AMGN in Q4 2023 and held it in 5 quarters. The position peaked at $83.9K in Q2 2024. 2,927 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

  • Transcendent Capital Group reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
  • Transcendent Capital Group sold 123 Amgen shares in Q1 2025, an estimated $32.1K.
  • Transcendent Capital Group first reported a position in Amgen in Q4 2023 and held it in 5 quarters.
  • Transcendent Capital Group's Amgen position peaked at $83.9K in Q2 2024.
  • 2,927 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on Transcendent Capital Group's 13F filing for Q1 2025, filed 2 May 2025.